June 8, 2017August 24, 2022
Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

The antibiotic omadacycline has displayed an ability to fight treatment-resistant respiratory, skin and urinary-tract bacteria in preclinical-trial studies, according to its maker, ... Read more
June 6, 2017June 6, 2017
Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

A combination of Salvecin (AR-301) and antibiotics eradicated ventilator-associated bacterial pneumonia (VABP) better than antibiotics alone, according to a Phase ... Read more
June 1, 2017June 1, 2017
PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

The PPV23 vaccine, designed to protect against community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae, is not uniformly effective among the general ... Read more
May 30, 2017May 30, 2017
Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

A combination of three antibiotics can eradicate two of today’s six most treatment-resistant bacteria, according to researchers at the State University ... Read more
May 25, 2017May 25, 2017
Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

A new study urges hospital intensive care units (ICUs) to adopt safety and hygiene protocols to reduce the occurrence of ... Read more
May 23, 2017May 23, 2017
Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

An initial antibiotics regimen fails to cure pneumonia in one in four patients who acquire the disease outside hospitals and ... Read more
May 18, 2017May 18, 2017
Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

A key immune system component called memory T-cells contributes to the naturally occurring protection against pneumonia-causing bacteria that the body develops ... Read more
May 16, 2017May 16, 2017
Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

The risk of having a heart attack increases 17 times in the seven days after a respiratory infection, including pneumonia, ... Read more
May 11, 2017May 11, 2017
Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

Doctors Without Borders will conduct a clinical study on ResApp Health‘s respiratory disease app ResAppDx in a lower-income rural setting, the ... Read more
May 9, 2017May 9, 2017
PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

PaxVax is modernizing a pneumonia virus vaccine that hasn’t been updated in 30 years, partly to help protect military recruits. Because ... Read more
May 4, 2017May 4, 2017
T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

T-follicular helper cells generate antibodies that prevent people from getting pneumococcal pneumonia, according to a Australian study whose findings offer important ... Read more
May 2, 2017May 2, 2017
Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests

Patients with community-acquired pneumonia (CAP) and treated with penicillin-G/V had less severe pneumonia than patients treated with broad-spectrum antibiotics or ... Read more

August 17, 2016August 17, 2016

Mortality from MRSA Pneumonia Following Influenza Caused by Immune Mechanisms

Influenza patients who get pneumonia caused by the superbug known as MRSA, (methicillin-resistant staphylococcus aureus) die from tissue damage caused by their own immune cells, rather than from direct consequences ... Read more

August 15, 2016August 15, 2016

Older Age and Wound Care Among Risk Factors for Drug-Resistant Pneumonia in Hospitals

Significant risk factors for pneumonia linked to drug-resistant pathogens in a healthcare setting — including in patients undergoing kidney dialysis, or hemodialysis — are advanced age, more severe pneumonia, and wound care, researchers reported. The study, which included as ... Read more

August 12, 2016

Case Report: Rare Lymphocytic Interstitial Lung Disease of Unknown Cause

Lymphocytic interstitial pneumonia (LIP), one of the rarest forms of interstitial lung disease (ILD), shares manifestations with a variety of other diseases, making it difficult to diagnose. Because patients with ... Read more

August 11, 2016August 12, 2016

Shorter Antibiotic Treatment for Pneumonia Shown to be Safe, Effective, and Likely Better than Longer Therapies

The optimal duration of antibiotic treatment for community-acquired pneumonia (CAP) has been debated for some time. A recent study shows that a shorter period of antibiotic therapy can be as ... Read more

August 10, 2016

Researchers Take Closer Look at Secondary Bacterial Pneumonia, Possibly Leading to New Treatments

Staphilococus aureus (S. aureus) is one of the most common causes of severe secondary bacterial pneumonia in patients with influenza A (a disease triggered by the H1N1 virus). It had ... Read more

August 9, 2016

Study Finds Woman’s Difficult-to-Treat Pneumonia Actually Case of Vasculitis

Non-resolving pneumonia can be a sign of a rare disease known as granulomatosis with polyangiitis, a type of vasculitis, researchers from the University of Ottawa in Canada report. A case study titled ... Read more

August 8, 2016

Antibiotic Prescription Errors Appear Linked to Ventilator-associated Pneumonia Deaths in Brazil, Study Shows

Ventilator-associated pneumonia (VAP) is frequently triggered by bacteria that are resistant to antibiotics, and is considered the most prevalent infection acquired in a hospital setting. Although there are guidelines for VAP ... Read more

August 5, 2016

Recomodulin May Help Specific Pneumonia Patients Suffering Acute Exacerbations, Study Suggests

Patients with idiopathic pulmonary fibrosis (IPF) or nonspecific interstitial pneumonia (NSIP) who experienced an acute exacerbation may benefit from Recomodulin (recombinant human soluble thrombomodulin), a new drug available for the ... Read more

August 4, 2016

AmpliPhi Completes Enrollment in Drug Trial for Hospital-Acquired Pneumonia, Other Infections

AmpliPhi Biosciences has completed enrollment for a Phase 1 clinical trial to evaluate the safety of AB-SAB01, its proprietary bacteriophage cocktail against Staphylococcus aureus (S. aureus) infections. Despite strong eradication efforts, S. ... Read more

August 3, 2016August 3, 2016

New Tool May Improve Pneumonia Diagnosis, Treatment in Poor Countries

Diagnosing pneumonia and its severity requires expensive equipment such as X-ray machines and laboratory services, but in developing countries where the majority of childhood pneumonia deaths occur, the equipment is ... Read more

August 2, 2016

Recovery from Pneumonia Slower in Smokers and Patients with Low Body Weight, Study Shows

Efferocytosis, a process whereby dying cells are engulfed and destroyed by other cells, is crucial in the recovery from pneumonia. However, this cellular cleaning is not as effective in smokers and ... Read more

August 1, 2016August 1, 2016

Doctors Without Borders Calls for Affordable Pneumonia Vaccines Before Pfizer’s Patent Hearing in India

Doctors Without Borders has established a new Access Campaign initiative ahead of Pfizer’s pneumonia patent hearing in India. In March 2016, the organization filed a “patent opposition” to prevent American pharmaceutical ... Read more

Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests